Geoffrey Douglas Block MD MSc, FACP
Advanced Endoscopic Interventional, Biliary Tract Disease, Hepatology & Liver Transplantation, Pancreas Disease
Professor of Medicine, Hepatology and Interventional Endoscopy, Director of Liver Transplant, Chief of Hepatology, Director of Thomas Boyer Liver Research Institute
Join to View Full Profile
University of Arizona; Thomas D. Boyer Liver Institute1501 N. Campbell Ave; Room 6309; PO Box 245136Tucson, AZ 85724
Phone+1 520-626-3005
Fax+1 520-626-5957
Dr. Block is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Geoffrey Block is an interventional/advanced gastroenterologist and transplant hepatologist in Tucson, AZ and is affiliated with Banner - University Medical Center and University of Arizona- Tucson. He received his medical degree from Wake Forest School of Medicine and has been in practice 33 years. He specializes in hepatology, liver transplantation, and advanced interventional endoscopy, to treat diseases and cancers of the bile ducts, liver, pancreas, and GI tract.
Education & Training
UPMC Medical EducationFellowship, Gastroenterology, 1989 - 1991- UPMC Medical EducationResidency, Internal Medicine, 1986 - 1989
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1984
Certifications & Licensure
AZ State Medical License 2019 - 2026
CA State Medical License 2014 - 2025
NC State Medical License 2010 - 2025
PA State Medical License 1988 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Clinical Trials
- Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein Start of enrollment: 2023 Mar 06
Roles: Principal Investigator
Publications & Presentations
PubMed
- 1 citationsDisparities in hepatocellular carcinoma incidence among Hispanic and non-Hispanic adults in Arizona: Trends between 2009-2017.Kristin E Morrill, Patrick Wightman, Alejandro Cruz, Ken Batai, Geoffrey D Block
Annals of Epidemiology. 2024-08-01 - 2 citationsThe prevalence and characteristics of misinformation on "TikTok" related to cirrhosis and liver disease: A comparative analysis of accurate and misleading content.Macklin Loveland, Ramzi Ibrahim, Geoffrey Block
Journal of Investigative Medicine. 2024-04-01 - 4 citationsMeasuring Medication Use, Obstacles, and Knowledge in Individuals With Cirrhosis.Archita P Desai, Shahd Duzdar, Timothy Stump, Eric S Orman, Lauren Nephew
Clinical Gastroenterology and Hepatology. 2023-07-01
Professional Memberships
- Fellow
- Member
- Transplant SocietyMember
- AASLDMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
